Small molecule · Acts on aggregated tau (paired helical filament tau / neurofibrillary tangles) · developed by Eli Lilly And Company
Flortaucipir F 18 is a radioactive PET imaging agent that binds to aggregated tau protein, including paired helical filament tau in neurofibrillary tangles. It is used to estimate the density and distribution of tau tangles in the brain of patients with cognitive impairment being evaluated for Alzheimer's disease.
Summary written with AI from the sources listed at the end of this page.
From the indications section of the FDA label (version of Dec 30, 2025). Read the full label for the exact wording, limitations and safety information.
Alzheimer Disease
Updated Nov 1, 2026. Something wrong or missing? Report it on the LLY page.
See LLY's upcoming FDA decisions, trial readouts, cash runway and dilution risk, updated every day from SEC, FDA and ClinicalTrials.gov filings.
LLY catalysts and pipeline →